References

All Party Parliamentary Group on Skin (1999). Report on the enquiry into fraudulent practice in the treatment of skin disease. London: All Party Parliamentary Group on Skin, Portcullis.

Asher, M.I., S. Montefort et al. (2006). Worldwide time trends in the prevalence of symptoms of asthma, allergic rhinoconjunctivitis, and eczema in childhood: ISAAC Phase One and Three repeat multicountry cross-sectional surveys. The Lancet, 368: 733–743.

Ben-Gashir, M.A., P.T. Seed et al. (2004). Quality of life and disease severity are correlated in children with atopic dermatitis. British Journal of Dermatology, 150(2): 284–290.

Boguniewicz, M., N. Nicol et al. (2008). A multidisciplinary approach to evaluation and treatment of atopic dermatitis. Seminars in Cutaneous Medicine and Surgery, 27: 115–127.

Bourke, J., I. Coulson et al. (2001). Guidelines for the care of contact dermatitis. British Journal of Dermatology, 145(6): 877–885.

Bridgett, C. (2000). Psychodermatology and atopic skin disease in London 1989–1999 – helping patients to help themselves. Dermatology and Psychosomatics/ Dermatologie und Psychosomatik, 1(4): 183–186.

Bridgett, C., P. Noren et al. (1996). Atopic Skin Disease: A Manual for Practitioners. Petersfiled: Wrightson Biomedical Publishing Limited.

British Medical Association and Royal Pharmaceutical Society of Great Britain (2009). British National Formulary. London, British Medical Journal Publishing Group Ltd and The Royal Pharmaceutical Society of Great Britain.

Brooks, J., S.J. Ersser et al. (2004). Nurseled education sets out to improve patient concordance and prevent recurrence of leg ulcers. Journal of Wound Care, 13(3): 111–116.

Burns, T., S. Breathnagh et al. (2004). Rook’s Textbook of Dermatology. Oxford: Blackwell Publishing Ltd.

Buske-Kirschbaum, A., A. Geiben et al. (2001). Psychobiological aspects of atopic dermatitis: An overview. Psychotherapy and Psychosomatics, 70: 6–16.

Buske-Kirschbaum, A., A. Gierens et al. (2002). Stress-induced immunomodulation is altered in patients with atopic dermatitis. Journal of Neuroimmunology, 129: 161–167.

Buxton, P.K. and R. Morris-Jones, Eds. (2009). ABC of Dermatology (5th edition). Chichester: Wiley-Blackwell and BMJ Books.

Chinn, D.J., T. Poyner et al. (2002). Randomized controlled trial of a single dermatology nurse consultation in primary care on the quality of life of children with atopic eczema. British Journal of Dermatology, 146(3): 432–439.

Cork, M.J. (1997). The importance of skin barrier function. Journal of Dermatological Treatments, 8: S7–S13.

Cork, M.J. (1999). Taking the itch out of eczema: How the careful use of emollients can break the itch–scratch cycle of atopic eczema. The Asthma Journal, 4: 116–120.

Cork, M.J., D.A. Robinson et al. (2006). New perspectives on epidermal barrier dysfunction in atopic dermatitis: Gene–environment interactions. Journal of Allergy and Clinical Immunology, 118: 3–21.

Cox, N.H. (1999). The expanding role of nurses in surgery and prescribing in British departments of dermatology. British Journal of Dermatology, 140(4): 681–684.

Cox, N.H. and C.M. Lawrence (1998). Diagnostic Problems in Dermatology. London: Mosby.

Department of Health (2000). The NHS Plan: A plan for investment, a plan for reform. London: Department of Health, Crown.

Department of Health (2008). Framing the Nursing and Midwifery Contribution: Driving up the quality of care, pp. 1–21. London: Department of Health, Crown.

DermNetNZ. (2009). Photocontact dermatitis. Retrieved 6 May 2009, from https://www. dermnetnz.org/reactions/photocontactdermatitis. html.

Ehlers, A., U. Gieler et al. (1995). Treatment of atopic dermatitis: A comparison of psychological and dermatological approaches to relapse prevention. Journal of Consulting & Clinical Psychology 63(4): 624–635.

Electronic Medicines Compendium. (2009a). Summary of product characteristics (SPC) for Protopic 0.03% and Protopic 0.1%., from https://emc.medicines.org.uk/document. aspx?documentId
8884.

Electronic Medicines Compendium. (2009b). Summary of product characteristics (SPC) for Neoral soft gelatine capsules and neural oral solution. Retrieved 14 April 2009, from https://emc.medicines.org.uk/ document.aspx?documentId
4106 and https://emc.medicines.org.uk/document. aspx?documentid
1307.

Elliott, B.E. and K. Luker (1997). The experiences of mothers caring for a child with severe atopic eczema. Journal of Clinical Nursing, 6: 214–217.

English, J. (1999). A Colour Handbook of Occupational Dermatology. London: Manson Publishing.

Ersser, S.J., S. Latter et al. (2007). Psychological and educational interventions for atopic eczema in children – Description. Cochrane Database of Systematic Reviews, 3: CD004054 (DOI: 10.1002/14651858. CD004054.pub2).


Fennessy, M., S. Coupland et al. (2000). The epidemiology and experience of atopic eczema during childhood: A discussion paper on the implications of current knowledge for health care, public health policy and research. Journal of Epidemiology and Community Health, 54(8): 581–589.

Giannini, A.V. (1997). Habit reversal technique and eczema. Journal of Allergy and Clinical Immunology, 100(4): 580.

Gradwell, C., K.S. Thomas et al. (2002). A randomized controlled trial of nurse followup clinics: Do they help patients and do they free up consultants’ time? British Journal of Dermatology, 147: 513–517.

Graham-Brown, R. and T. Burns (2006). Lecture Notes: Dermatology (9th edition). Oxford: Blackwell Publishing.

Graham-Brown, R.A.C., J.F. Bourke et al. (1994). Letters: Chinese herbal remedies may contain steroids. British Medical Journal, 308: 473.

Guevara, J.P., J.P. Wolf et al. (2003). Effects of interventions for self management of asthma in children and adolescents: Systematic review and meta analysis. British Medical Journal, 326: 1308–1309.

Hagermark, O. and C.F. Wahlgren (1995). Treatment of itch. Seminars in Dermatology, 14(4): 320–325.

Hanifin, J.M. and G. Rajka (1980). Diagnostic features of atopic dermatitis. Acta Dermato Venereologica (Stockholm), 92: 44–47.

Herd, R.M. (2000). The morbidity and cost of atopic dermatitis. In: Williams, H.C. (Ed.), Atopic Dermatitis, pp. 85–95. Cambridge: Cambridge University Press.

Herd, R., M.J. Tidman et al. (1996). Prevalence of atopic eczema in the community: The Lothian atopic dermatitis study. British Journal of Dermatology, 135: 18–19.

Hoare, C., A. Li Wan Po and H. Williams (2000). Systematic review of treatments for atopic eczema. Health Technology Assessment, 4: 1–19.

Holman, H. and K. Lorig (2000). Patients as partners in managing chronic disease – Partnership is a prerequisite for effective and efficient health care. British Medical Journal, 320(7234): 526–527.

Horne, D.J.D., A.E. White et al. (1989). A preliminary study of psychological therapy in the management of atopic eczema. British Journal of Medical Psychology, 62: 241–248.

Hultsch, T., A. Kapp et al. (2005). Immunomodulation and safety of topical calcineurin inhibitors for the treatment of atopic dermatitis. Dermatology, 211: 174–187.

Kemp, A.S. (2003). Cost of illness of atopic dermatitis in children: a societal perspective. Pharmacoeconomics, 21: 105–113.

Leung, D.Y.M. (2000). Atopic dermatitis: New insights and opportunities for therapeutic intervention. Journal of Allergy and Clinical Immunology, 5(105): 860–876.

Lewis-Jones, M.S. and A.Y. Finlay (1995). The children’s dermatology life quality index (CDLQI): Initial validation and practical use. British Journal of Dermatology, 132: 942–949.

Lewis-Jones, M.S., A.Y. Finlay et al. (2001). The infants’ dermatitis quality of life index. British Journal of Dermatology, 144: 104–110.

Lifschitz, C. (2008). Is there a consensus in food allergy management. Journal of Paediatric Gastroenterology Nutrition, 47(Suppl 2): S58–S59.

Long, C.C. and A.Y. Finlay (1991). The fingertip unit – a new practical measure. Clinical and Experimental Dermatology, 16(6): 444–447.

McFadden, J.P., W.C. Noble et al. (1993). Superantigenic exotoxin-secreting potential of staphylococci isolated from atopic eczematous skin. British Journal of Dermatology, 128: 631–632.

McNally, N.J., H.C. Williams et al. (2001). Atopic eczema and the home environment. British Journal of Dermatology, 145(5): 730–736.

National Eczema Society (2009). Frequently asked questions on eczema: What about complementary therapies? from https://www.eczema.org/faq.php?act=cli.faq_view&id_faq=15&id_domain=0&question=&sql_indx=1&faq_indx=6.

National Institute for Health and Clinical Excellence (NICE) (2004a). Frequency of application of topical corticosteroids for atopic eczema, 34p. London: National Institute for Health and Clinical Excellence (NICE).

National Institute for Health and Clinical Excellence (NICE) (2004b). Tacrolimus and primecrolimus for atopic eczema. London: NICE.

National Institute for Health and Clinical Excellence (NICE) (2007). Atopic eczema in children: Management of atopic eczema in children from birth up to the age of 12 years, from https://www.ncc-wch.org.uk/index. asp?PageID
359.

Nicol, N.H. and M. Boguniewicz (2008). Successful strategies in atopic dermatitis management. Dermatology Nursing Supplement: 1–19.

Niebel, G., C. Kallweit et al. (2000). Direct versus video-based parental education in the treatment of atopic eczema in children. A controlled pilot study [Direkte versus videovermittelte Elternschulung bei atopischem Ekzem im Kindesalter als Erganzung facharztlicher Behandlung. Eine Kontrollierte Pilotstudie]. Hautarzt, 51: 401–411.

Noren, P. (1995). Habit reversal – a turning point in the treatment of atopic dermatitis. Clinical and Experimental Dermatology, 20(1): 2–5.

Palmer, C.N., A.D. Irvine et al. (2006). Common loss-of-function variants of the epidermal barrier protein filaggrin are a major predisposing factor for atopic dermatitis. Nature Genetics, 38: 441–446.

Penzer, R. (2003). How to set up an eczema clinic in primary care. London: National Eczema Society.

Picardo, M. and N. Cameli (2008). Seborrheic dermatitis. In: Williams, H.C., Bigby, M., Diepgen, T. et al. (Eds), Evidence-based Dermatology, pp. 164–170. Oxford: Blackwell Publishing/BMJ Books.

Primary Care Dermatology Society and British Association of Dermatologists (2006). Guidance for the management of atopic eczema: ECDS & BAD, from https://www. eGuidelines.co.uk/skin, 28: 372–375.

Radcliffe, J. (1998). How to … conduct a patch test. British Journal of Dermatological Nursing, 2(4): 8–9.

Reid, P. and M.S. Lewis-Jones (1995). Sleep disturbances and their management in pre-schoolers with atopic eczema. Clinical Experimental Dermatology, 20: 38–41.

Sheenan, M.P. and D.J. Atherton (1994). One year follow-up of children treated with Chinese medicinal herbs for atopic eczema. British Journal of Dermatology, 130: 488–493.

Simpson-Dent, S.L., R.C.D. Staughton et al. (1999). The combined approach to chronic atopic eczema. A prospective comparison of behavioural modification with standard dermatological treatment against standard treatment alone. Paris: Proceedings of the International Congress of Dermatological Psychiatry.

Sokel, B., D. Christie et al. (1993). A comparison of hypnotherapy and biofeedback in the treatment of childhood atopic eczema. Contemporary Hypnosis, 10(3): 145–154.

Staab, D., U. von Rueden et al. (2002). Evaluation of a parental training program for the management of atopic dermatitis. Pediatric Allergy and Immunology, 13: 84–90.

Staab, D., T.L. Diepgen et al. (2006). Age related, structured educational programmes for the management of atopic dermatitis in children and adolescents: Multicentre, randomised controlled trial. British Medical Journal, 332: 933–938.

Strachan, D.P. (1989). Hayfever, hygiene and household size. British Medical Journal, 299: 1259–1290.

Surridge, H.R. (2005). Exploring parental needs and knowledge when caring for a child with eczema. Patient Magazine of the National Eczema Society.

Szakos, E., G. Lakos et al. (2004). Relationship between skin bacterial colonization and the occurrence of allergen-specific and nonallergen- specific antibodies in sera of children with atopic eczema/dermatitis syndrome. Acta Dermato-Venereologica, 84(1): 32–36.

Taal, E., E. Rasker et al. (1993). Health status, adherence with health recommendations, self-efficacy and social support in patients with rheumatoid arthritis. Patient Education Counseling, 20: 63–76.

Thomas, K., F. Bath-Hextall et al. (2008). Atopic eczema. In: Williams, H.C., Bigby, M., Diepgen, T. et al. (Eds), Evidence-based Dermatology. Oxford: Blackwell Publishing Ltd.

Verboom, P., L. Hakkaart-Van et al. (2002). The cost of atopic dermatitis in the Netherlands: An international comparison. British Journal of Dermatology, 147(4): 716–724.

Weller, R., J.A.A. Hunter, J. Savin and M. Dahl (2008). Clinical Dermatology (4th edition). Oxford: Blackwell Publishing Ltd.

Williams, H.C. (1992). Is the prevalence of atopic dermatitis increasing? Clinical and Experimental Dermatology, 17(6): 385–391.

Williams, H.C. (1995). Atopic eczema – why we should look at the environment. British Medical Journal, 311: 1241–1242.

Williams, H.C. (1997). Dermatology: Health Care Needs Assessment. Oxford: Radcliffe Medical Press.
Williams, H., H. Forsdyke et al. (1995). A protocol for recording the sign of visible flexural dermatitis. British Journal of Dermatology, 133: 941–949.

Williams, H., M. Bigby et al. (2008). Evidencebased Dermatology. Oxford: BMJ Books, Blackwell Publishing.